Can We Better Protect Hospitalized Patients With Obesity From Venous Thromboembolism? – RPTH Journal
RPTH Journal shared a post on LinkedIn about a recent article by Walter Agenoet et al, adding:
”Can we better protect hospitalized patients with obesity from venous thromboembolism?
Patients with obesity hospitalized for acute medical illness face a substantial risk of venous thromboembolism (VTE), yet optimal thromboprophylaxis strategies remain uncertain.
In this large real-world analysis of 58,186 hospitalized adults receiving enoxaparin, researchers evaluated treatment patterns, clinical outcomes, and predictors of VTE and major bleeding (MB).
More than half of patients (56.9 percent) received high-dose enoxaparin (more than 40 mg/day), but prophylaxis was typically shorter than hospitalization (median 3 days compared with 4 days), and only 1.3 percent received post-discharge enoxaparin.
Despite prophylaxis, the cumulative 90-day incidence reached 3.2 percent for venous thromboembolism compared with 1.8 percent for major bleeding, suggesting that thrombotic risk outweighed bleeding risk in this population.
The highest venous thromboembolism risk occurred in patients hospitalized with cancer (7.8 percent), while a history of venous thromboembolism emerged as the strongest predictor of recurrent thrombosis (hazard ratio 4.1). A history of major bleeding was the strongest predictor of future major bleeding (hazard ratio 2.8). These findings support more individualized risk assessment, particularly for patients with cancer, severe obesity, or prior venous thromboembolism.
As obesity continues to rise worldwide, optimizing the dose, duration, and personalization of thromboprophylaxis remains an important clinical challenge.
Title: Venous thromboembolic and bleeding risk in population with obesity hospitalized for an acute medical illness receiving enoxaparin for thromboprophylaxis
Authors: Walter Ageno, Juan I. Arcelus, Christine Stroh, Yasmina Djoudi, Mohamed Abdel-Moneim, Irfan Khan, Ekaterina Ponomareva, Marc Carrier
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 30, 2026, 16:05Peter Zdziarski: Today is Chronic Disease Awareness Day
-
Jul 30, 2026, 15:50Ahmad Gharehbaghian: New Blood Transfusion Centers Open in Iran
-
Jul 30, 2026, 15:162025 Platelet Transfusion Thresholds: When to Transfuse and When Not to Transfuse – Chokri Ben Lamine
-
Jul 30, 2026, 14:34Flora Peyvandi: Genetics of Early-Onset Coronary Artery Disease in Iranians
-
Jul 30, 2026, 14:22Stéphanie Forté: New Evidence Strengthens the Case for Hydroxyurea in HbSC Disease
-
Jul 30, 2026, 14:09Hilal Ahmad: New Guidelines for Pediatric Ischemic Stroke Management
-
Jul 30, 2026, 14:05Aleksandra Jaworucka- Kaczorowska: Hands-On Venous Duplex Ultrasound Training
-
Jul 30, 2026, 13:55Evgenii Glukhaniuk: New Review Highlights the Role of Platelets in Cancer Progression and Thrombosis
-
Jul 30, 2026, 13:32William Aird: Interpreting Polyclonal Gammopathy